Bell Investment Advisors, Inc Ascendis Pharma A/S Transaction History
Bell Investment Advisors, Inc
- $533 Million
- Q4 2024
A detailed history of Bell Investment Advisors, Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 44 shares of ASND stock, worth $6,714. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44
Previous 57
22.81%
Holding current value
$6,714
Previous $8,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ASND
# of Institutions
236Shares Held
60.2MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.54 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$844 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$779 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$679 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$668 Million0.32% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.52B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...